# Intrathecal Morphine vs. Intrathecal Morphine and Regional Anesthesia After Cesarean Section.

> **NCT06114121** · PHASE4 · WITHDRAWN · sponsor: **University of Miami**

## Conditions studied

- Post-operative Pain

## Interventions

- **PROCEDURE:** erector spinae plane block (ESP)
- **DRUG:** Duramorph
- **DRUG:** Ropivacaine
- **DRUG:** Bupivacaine Injection

## Key facts

- **NCT ID:** NCT06114121
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-07-10
- **Primary completion:** 2024-09-10
- **Final completion:** 2024-09-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study will no longer be conducted
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06114121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06114121, "Intrathecal Morphine vs. Intrathecal Morphine and Regional Anesthesia After Cesarean Section.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06114121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*